1
|
Y TomitaT SuzukiGenetics of pigmentary
disordersAm J Med Genet C Semin Med
Genet1317581200410.1002/ajmg.c.30036
|
2
|
K GrønskovJ EkK
Brondum-NielsenOculocutaneous albinismOrphanet J Rare
Dis243200719006216
|
3
|
WS OettingRA KingMolecular basis of
albinism: mutations and polymorphisms of pigmentation genes
associated with albinismHum
Mutat1399115199910.1002/(SICI)1098-1004(1999)13:2%3C99::AID-HUMU2%3E3.0.CO;2-C10094567
|
4
|
C RooryckC RoudautE RobineJ MusebeckB
ArveilerOculocutaneous albinism with TYRP1 gene mutations in a
Caucasian patientPigment Cell
Res19239242200610.1111/j.1600-0749.2006.00298.x16704458
|
5
|
K InagakiT SuzukiH ShimizuOculocutaneous
albinism type 4 is one of the most common types of albinism in
JapanAm J Hum Genet74466471200410.1086/38219514961451
|
6
|
T SuzukiY TomitaRecent advances in genetic
analyses of oculocutaneous albinism types 2 and 4J Dermatol
Sci5119200810.1016/j.jdermsci.2007.12.00818407468
|
7
|
A WeiY WangY LongA comprehensive analysis
reveals mutational spectra and common alleles in Chinese patients
with oculocutaneous albinismJ Invest
Dermatol130716724201010.1038/jid.2009.33919865097
|
8
|
SK ParkKH LeeKC ParkJS LeeRA SpritzST
LeePrevalent and novel mutations of the tyrosinase gene in Korean
patients with tyrosinase-deficient oculocutaneous albinismMol
Cells718719119979163730
|
9
|
T SuzukiK InagakiK FukaiA ObanaST LeeY
TomitaA Korean case of oculocutaneous albinism type IV caused by a
D157N mutation in the MATP geneBr J
Dermatol152174175200510.1111/j.1365-2133.2005.06403.x
|
10
|
PC NgS HenikoffSIFT: predicting amino acid
changes that affect protein functionNucleic Acids
Res3138123814200310.1093/nar/gkg50912824425
|
11
|
V RamenskyP BorkS SunyaevHuman
non-synonymous SNPs: server and surveyNucleic Acids
Res3038943900200210.1093/nar/gkf49312202775
|
12
|
BS KwonAK HaqSH PomerantzR
HalabanIsolation and sequence of a cDNA clone for human tyrosinase
that maps at the mouse c-albino locusProc Natl Acad Sci
USA8474737477198710.1073/pnas.84.21.74732823263
|
13
|
CJ CookseyPJ GarrattEJ LandEvidence of the
indirect formation of the catecholic intermediate substrate
responsible for the autoactivation kinetics of tyrosinaseJ Biol
Chem2722622626235199710.1074/jbc.272.42.262269334191
|
14
|
H WatabeJC ValenciaK YasumotoRegulation of
tyrosinase processing and trafficking by organellar pH and by
proteasome activityJ Biol
Chem27979717981200410.1074/jbc.M30971420014634018
|
15
|
K ToyofukuI WadaRA SpritzVJ HearingThe
molecular basis of oculocutaneous albinism type 1 (OCA1): sorting
failure and degradation of mutant tyrosinases results in a lack of
pigmentationBiochem
J355259269200110.1042/0264-6021:355025911284711
|
16
|
KC ParkSK ParkYS LeeMutations of the
tyrosinase gene in three Korean patients with type I oculocutaneous
albinismJpn J Hum Genet41299305199610.1007/BF019131728996965
|
17
|
The Human Gene Mutation Databasehttp://www.hgmd.cf.ac.uk/ac/all.phpAccessed September
1, 2011
|
18
|
Albinism database: Mutations of the
tyrosinase gene associated with OCA1http://albinismdb.med.umn.edu/oca1mut.htmlAccessed
September 1, 2011
|
19
|
M GotoKC Sato-MatsumuraD SawamuraK YokotaH
NakamuraH ShimizuTyrosinase gene analysis in Japanese patients with
oculocutaneous albinismJ Dermatol
Sci35215220200410.1016/j.jdermsci.2004.06.00715381243
|
20
|
Y TomitaY MiyamuraM KonoR NakamuraJ
MatsunagaMolecular bases of congenital hypopigmentary disorders in
humans and oculocutaneous albinism 1 in JapanPigment Cell
Res13Suppl 8130134200010.1034/j.1600-0749.13.s8.23.x11041370
|
21
|
RA KingJ PietschJP FryerTyrosinase gene
mutations in oculocutaneous albinism 1 (OCA1): definition of the
phenotypeHum
Genet113502513200310.1007/s00439-003-0998-113680365
|
22
|
K RayM ChakiM SenguptaNovel human
pathological mutations. Gene symbol: TYR Disease: tyrosinase
deficiencyHum Genet1225562007
|
23
|
S FukamachiA ShimadaA ShimaMutations in
the gene encoding B, a novel transporter protein, reduce melanin
content in medakaNat Genet28381385200110.1038/ng58411479596
|
24
|
ME RayG WistowYA SuPS MeltzerJM TrentAIM1,
a novel non-lens member of the betagamma-crystallin super-family,
is associated with the control of tumorigenicity in human malignant
melanomaProc Natl Acad Sci
USA9432293234199710.1073/pnas.94.7.32299096375
|
25
|
GE CostinJC ValenciaWD VieiraML LamoreuxVJ
HearingTyrosinase processing and intracellular trafficking is
disrupted in mouse primary melanocytes carrying the underwhite (uw)
mutation. A model for oculocutaneous albinism (OCA) type 4J Cell
Sci11632033212200310.1242/jcs.00598
|
26
|
JM NewtonO Cohen-BarakN HagiwaraMutations
in the human orthologue of the mouse underwhite gene (uw) underlie
a new form of oculocutaneous albinism, OCA4Am J Hum
Genet69981988200110.1086/32434011574907
|
27
|
U RundshagenC ZuhlkeS OpitzE SchwingerB
Kasmann-KellnerMutations in the MATP gene in five German patients
affected by oculocutaneous albinism type 4Hum
Mutat23106110200410.1002/humu.1031114722913
|
28
|
A GargiuloF TestaS RossiMolecular and
clinical characterization of albinism in a large cohort of Italian
patientsInvest Ophthalmol Vis
Sci1412811289201110.1167/iovs.10-609120861488
|
29
|
K InagakiT SuzukiS ItoOCA4: evidence for a
founder effect for the p.D157N mutation of the MATP gene in
Japanese and KoreanPigment Cell
Res18385388200510.1111/j.1600-0749.2005.00261.x16162179
|